Sirolimus 2mg Tablet

Sirolimus 2mg Tablet is a prescription immunosuppressant containing sirolimus, also known as rapamycin. It is used primarily as part of immunosuppressive therapy to help prevent rejection following kidney transplantation and, depending on the country and product, for other specialist indications. Rapamune® 2mg is the reference brand containing sirolimus, while generic sirolimus 2mg tablets are available from multiple manufacturers in some markets.

Product Information

Generic Name

Sirolimus 2mg

Active Ingredient

Sirolimus

Also Known As

Rapamycin

Drug Class

Immunosuppressant; mTOR Inhibitor

Brand Reference

Rapamune® 2mg

Primary Indication

Prevention of organ rejection following kidney transplantation

Dosage Form

Oral Tablet

Strength

2mg

Route

Oral

Prescription

Yes

Therapeutic Drug Monitoring

Required in appropriate transplant patients

Regulatory Status

Prescription medicine; indications and formulations vary by country

Sirolimus 2mg for Transplant Rejection Prevention

Following an organ transplant, the immune system can recognize the transplanted organ as foreign and mount an immune response against it.

Sirolimus reduces this immune response and may be incorporated into a broader immunosuppressive regimen. It is commonly used in combination with other transplant medicines according to a specialist-designed treatment plan.

Because sirolimus has a narrow therapeutic range, blood-level monitoring is an important part of treatment for appropriate patients.

Generic Sirolimus 2mg vs Rapamune® 2mg

Sirolimus is the generic active ingredient, while Rapamune® is a branded product containing sirolimus.

Therefore:

• Sirolimus 2mg Tablet = generic medicine containing sirolimus
• Rapamune® 2mg = branded/reference sirolimus product
• Generic Sirolimus 2mg = equivalent active pharmaceutical ingredient, subject to the applicable regulatory approval

Generic availability and authorized manufacturers differ between countries.

Monitoring During Sirolimus Treatment

Healthcare professionals may monitor:

• Sirolimus blood concentrations
• Kidney function
• Liver function
• Complete blood count
• Blood pressure
• Serum lipids
• Urinary protein
• Signs of infection
• Signs of malignancy
• Wound healing

Therapeutic drug monitoring is particularly important because insufficient exposure can increase rejection risk, while excessive exposure can increase toxicity.

Availability & Ordering

Commercial searches associated with this medicine include Sirolimus 2mg Tablet, Buy Sirolimus 2mg, Generic Rapamune 2mg, Sirolimus 2mg price, Sirolimus 2mg online pharmacy, and Sirolimus 2mg transplant medicine.

Sirolimus is a prescription immunosuppressant and should only be obtained from a legitimate, appropriately regulated pharmacy or supplier. Prescription requirements, approved indications, manufacturers, and import regulations vary by country.

How it works

Sirolimus inhibits mechanistic target of rapamycin (mTOR), an intracellular signaling pathway involved in cellular growth, proliferation, metabolism, and immune-cell activation.

By forming a complex with FKBP-12, sirolimus inhibits mTORC1 signaling. This suppresses T-lymphocyte activation and proliferation, thereby reducing the immune response that can contribute to transplant rejection.

Sirolimus is primarily used as an immunosuppressive medicine in transplant medicine.

Depending on the approved product and jurisdiction, sirolimus may be used for:

• Prevention of kidney transplant rejection
• Maintenance immunosuppression following transplantation
• Combination immunosuppressive therapy with other transplant medicines
• Selected specialist uses involving abnormal lymphatic or vascular growth, depending on local authorization

The exact treatment regimen is individualized according to the transplanted organ, concurrent immunosuppressants, blood concentrations, kidney and liver function, and other clinical factors.

Sirolimus significantly suppresses immune-system activity and therefore requires specialist medical supervision.

Important risks and adverse effects may include:

• Increased susceptibility to infections
• Increased risk of certain malignancies with long-term immunosuppression
• Elevated blood lipid levels
• Reduced blood-cell counts
• Mouth ulcers
• Diarrhea
• Headache
• Hypertension
• Peripheral edema
• Impaired wound healing
• Proteinuria
• Abnormal kidney function
• Interstitial lung disease or pneumonitis
• Hypersensitivity reactions

Sirolimus can also interact with numerous medicines, particularly medicines affecting CYP3A4 and P-glycoprotein pathways. Grapefruit and grapefruit juice may also affect sirolimus exposure.

Because blood concentrations can change substantially with drug interactions and changes in formulation or dosing, patients should not change their sirolimus product, dose, or treatment schedule without specialist guidance.